ELEVATED LEVELS OF ASYMMETRIC DIMETHYLARGININE (ADMA) AND SYMMETRIC DIMETHYLARGININE (SDMA) CORRELATE WITH KIDNEY FUNCTION AND PREDICT OUTCOMES IN CHRONIC KIDNEY DISEASE PATIENTS

ELEVATED LEVELS OF ASYMMETRIC DIMETHYLARGININE (ADMA) AND SYMMETRIC DIMETHYLARGININE (SDMA) CORRELATE WITH KIDNEY FUNCTION AND PREDICT OUTCOMES IN CHRONIC KIDNEY DISEASE PATIENTS

Bibliographic Details
Main Authors:	Landray, M, Dalton, N, Turner, C, Blackwell, L, Morgan, M, Nuttall, S, Baigent, C, Townend, J, Wheeler, D
Format:	Journal article
Published:	2005

Similar Items

Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA)
by: You‐Lin Tain, et al.
Published: (2017-03-01)

Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes
by: Dimitrios Tsikas, et al.
Published: (2018-01-01)

Symmetrical (SDMA) and asymmetrical dimethylarginine (ADMA) in sepsis: high plasma levels as combined risk markers for sepsis survival
by: Martin Sebastian Winkler, et al.
Published: (2018-09-01)

Evaluation of Symmetric Dimethylarginine (SDMA) in Dogs with Acute Pancreatitis
by: Eleonora Gori, et al.
Published: (2020-06-01)

Asymmetric Dimethylarginine (ADMA) level in Serum of Preeclamptic patients
by: Faisal Gh. Al-Rubaye
Published: (2010-01-01)

Asymmetric dimethylarginine (ADMA) and endothelial dysfunction: implications for atherogenesis
by: Maurício Batista Paes Landim, et al.
Published: (2009-05-01)

P.041 ARTERIAL STIFFNESS MAY BE DETERMINED BY ASYMMETRIC DIMETHYLARGININE (ADMA)
by: S. Hickson, et al.
Published: (2007-08-01)

Elevated Levels of Asymmetric Dimethylarginine (ADMA) in the Pericardial Fluid of Cardiac Patients Correlate with Cardiac Hypertrophy.
by: Zoltan Nemeth, et al.
Published: (2015-01-01)

Alterations of Asymmetric Dimethylarginine (ADMA)-Containing Protein Profiles Associated with Chronic Pancreatitis Pathogenesis
by: Tan C, et al.
Published: (2021-12-01)

Asymmetric dimethylarginine (ADMA) increases the myogenic tone of arterioles due to enhanced release of superoxide
by: Toth, J, et al.
Published: (2007)

Analysis of Ghrelin and Asymmetric Dimethylarginine (ADMA) as Endothelial Dysfunction Marker Among Obese Men
by: Lia Meliani, et al.
Published: (2012-08-01)

Evaluation of symmetric dimethylarginine in cats with acute kidney injury and chronic kidney disease
by: Samantha C. Loane, et al.
Published: (2022-09-01)

Serum concentrations of symmetric dimethylarginine and creatinine in cats with kidney stones.
by: Jean A Hall, et al.
Published: (2017-01-01)

Asymmetric Dimethylarginine (ADMA) in Pediatric Renal Diseases: From Pathophysiological Phenomenon to Clinical Biomarker and Beyond
by: Chien-Ning Hsu, et al.
Published: (2021-09-01)

The role of asymmetric dimethylarginine (ADMA) in COVID-19: association with respiratory failure and predictive role for outcome
by: Emanuela Sozio, et al.
Published: (2023-06-01)

The protective effect of dronedarone on the structure and mechanical properties of the aorta in hypertensive rats by decreasing the concentration of symmetric dimethylarginine (SDMA).
by: Begoña Quintana-Villamandos, et al.
Published: (2019-01-01)

Increased Serum Levels of Asymmetric Dimethylarginine and Symmetric Dimethylarginine and Decreased Levels of Arginine in Sudanese Patients with Essential Hypertension
by: Sahar Gamil, et al.
Published: (2020-08-01)

Dimethylarginine: Biomarkers in progression of kidney disease
by: Cvetković Tatjana, et al.
Published: (2012-01-01)

Evaluation of renal injury and function biomarkers, including symmetric dimethylarginine (SDMA), in the rat passive Heymann nephritis (PHN) model.
by: Michael J Coyne, et al.
Published: (2022-01-01)

Author Correction: The role of asymmetric dimethylarginine (ADMA) in COVID-19: association with respiratory failure and predictive role for outcome
by: Emanuela Sozio, et al.
Published: (2023-06-01)

Urinary Dimethylamine (DMA) and Its Precursor Asymmetric Dimethylarginine (ADMA) in Clinical Medicine, in the Context of Nitric Oxide (NO) and Beyond
by: Dimitrios Tsikas
Published: (2020-06-01)

Correlation between Homeostatic Model Assessment-estimated Insulin Resistance (HOMA-IR) with Asymmetric Dimethylarginine (ADMA) in Prehypertension
by: Maria Evi Novianti, et al.
Published: (2013-12-01)

Detecting acute kidney injury in horses by measuring the concentration of symmetric dimethylarginine in serum
by: Natalia Siwinska, et al.
Published: (2021-01-01)

Serum symmetric dimethylarginine concentration in healthy horses and horses with acute kidney injury
by: Natalia Siwinska, et al.
Published: (2020-10-01)

Reliability of symmetric dimethylarginine in dogs with myxomatous mitral valve disease as kidney biomarker
by: Alice Savarese, et al.
Published: (2018-08-01)

Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis.
by: Antoniades, C, et al.
Published: (2009)

Serum Concentrations of Symmetric Dimethylarginine and Creatinine in Dogs with Naturally Occurring Chronic Kidney Disease
by: J.A. Hall, et al.
Published: (2016-05-01)

Response to Asymmetrical Dimethylarginine, Oxidative Stress, and Atherosclerosis
by: Antoniades, C, et al.
Published: (2011)

ELEVATED LEVELS OF N-TERMINAL BRAIN NATRIURETIC PEPTIDE AND TROPONIN T CORRELATE WITH KIDNEY FUNCTION AND PREDICT OUTCOMES IN CHRONIC KIDNEY DISEASE PATIENTS
by: Landray, M, et al.
Published: (2005)

Effect of Lowering Asymmetric Dimethylarginine (ADMA) on Vascular Pathology in Atherosclerotic ApoE-Deficient Mice with Reduced Renal Mass
by: Johannes Jacobi, et al.
Published: (2014-03-01)

Positive correlation of airway resistance and serum asymmetric dimethylarginine (ADMA) in bronchial asthma patients lacking evidence for systemic inflammation
by: Gabor Tajti, et al.
Published: (2018-01-01)

Variability of Symmetric Dimethylarginine in Apparently Healthy Dogs
by: M.A. Kopke, et al.
Published: (2018-03-01)

Role of Asymmetric Dimethylarginine in Psychiatric Disorders
by: Selma Bozkurt Zincir, et al.
Published: (2014-08-01)

Renal asymmetric dimethylarginine inhibits fibrosis
by: Ming Wu, et al.
Published: (2020-10-01)

Asymmetric and Symmetric Dimethylarginines as Renal Function Parameters in Paediatric Kidney Diseases: A Literature Review from 2003 to 2022
by: Michalina Jezierska, et al.
Published: (2022-10-01)

Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC-MS/MS versus ELISA
by: Jente Boelaert, et al.
Published: (2016-05-01)

Is symmetric dimethylarginine superior to creatinine for assessing glomerular filtration rate for cats with kidney disease?
by: Lorna Hardy
Published: (2023-10-01)

Variability of symmetric dimethylarginine in apparently healthy dogs
by: Randolph M. Baral, et al.
Published: (2019-01-01)

SERUM LIPIDS DO NOT PREDICT CARDIOVASCULAR OUTCOMES IN CHRONIC KIDNEY DISEASE PATIENTS
by: Landray, M, et al.
Published: (2005)

α-Klotho, Plasma Asymmetric Dimethylarginine, and Kidney Disease ProgressionPlain-Language Summary
by: Jing Qian, et al.
Published: (2021-11-01)